Biotechnology professional with over twenty years of experience conducting and overseeing innovative, cross-functional research. Experience covering the drug development process from target validation and lead selection through phase III clinical trials. Modalities including monoclonal antibody, Probody™, recombinant protein and oligopeptide-based therapeutics in oncology, inflammation and infectious disease. Experienced team lead who thrives in dynamic, fast paced environments and has proven expertise in the management of complex research projects.